# Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant

> **NCT01386359** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 914 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** No Intervention

## Key facts

- **NCT ID:** NCT01386359
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-29
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 914 (ACTUAL)
- **Last updated:** 2022-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386359, "Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01386359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*